-
2024-515625-29-00
5
2020-06-16
Apnea of prematurity
-
2024-518568-11-00
4
2019-02-04
Hematological malignancies confirmed histologically:
- AML in morphol
-
2023-506857-40-00
5
2019-01-08
Prostate Cancer
-
2025-521067-13-00
5
2026-04-24
Atherosclerotic Cardiovascular Disease (ASCVD)
-
2025-521918-26-00
4
2026-02-11
HIV Infections
-
2024-517356-35-00
4
2025-07-29
Moderately Active Rheumatoid Arthritis
-
2024-513307-13-00
4
2025-05-26
Advanced/metastatic solid tumors including gynecological
cancers (endo
-
2024-511016-25-00
4
2025-01-15
Chronic hepatitis B infection
-
2024-515070-28-00
5
2024-12-23
HIV Infections
-
2023-505617-24-00
4
2024-11-05
Recurrent Ovarian Cancer with High Folate Receptor-Alpha Expression
-
2023-509716-29-00
9
2024-09-23
Solid Tumors, Colorectal Cancer and Breast Cancer
-
2023-509190-23-00
5
2024-09-03
Atherosclerotic Cardiovascular Disease
Elevated lp(a)
-
2024-510908-37-00
5
2024-08-28
KRAS G12C-Positive Advanced or Metastatic Non-Small Cell Lung Cancer (
-
2023-506053-38-00
1
2024-08-27
Advanced or metastatic malignant solid tumors
-
2023-508896-35-00
6
2024-07-12
Infertile women with at least one patent tube at Hysterosalpingo-foam
-
2024-512023-37-00
4
2024-06-27
Prostate cancer
-
2022-500714-25-01
5
2024-06-19
congenital CMV infection
-
2023-508630-34-00
5
2024-05-28
Overweight
-
2023-508166-15-00
6
2024-04-29
Ulcerative colitis (UC), Inflammatory bowel disease type unclassified
-
2023-503231-17-00
5
2024-04-26
Unresectable Pleural Mesothelioma
-
2023-505928-59-00
5
2024-04-15
Triple Negative or Hormone Receptor low/HER2-negative Breast Cancer
-
2023-504471-25-00
5
2024-03-01
Fibrotic Lung Disease
-
2023-504993-40-00
5
2024-02-14
Human immunodeficiency virus (HIV)
-
2023-506139-13-00
5
2024-01-04
Treatment naïve patients with MF